Page 3 - Nifty Pharma

Nifty Metal, Pharma: Trading strategies for these 2 sectoral indices

According to Ravi Nathani, an independent technical analyst, the Nifty Metal index seems to be trading in a range-bound manner, with a negative bias; whereas, the outlook seems positive for the Pharma

Nifty Pharma, Auto: Here's a guide to plan your trading activity

According to Ravi Nathani, an independent technical analyst, the Nifty Pharma and Auto indices are at critical junctures, hence one needs to watch out for these key levels for planing trades.

Sell Nifty Auto index on rise as charts show bearish near-term trend

The pivot level for this month, for example, is at 15,550, further supporting the case for a potential downward move in Nifty Auto index

Trading guide for Nifty Pharma, Media indices for the near-term

According to Ravi Nathani, an independent technical analyst, the Nifty Pharma and Media indices are likely to consolidate, with the latter likely to trade with a negative bias.

Cipla, Glenmark: Time to accumulate pharma stocks on robust bullish trend?

The current volatility in the benchmark indices offer the ideal opportunity to accumulate pharma stocks around their respective supports

Nifty Pharma nears overbought zone after it scales record high, show charts

According to Ravi Nathani, an independent technical analyst, said that Nifty Pharma's recent surge to all-time high signals strong positive sentiment, but proximity to overbought levels needs caution

Nifty Metal to be range-bound; Pharma index bullish with need for caution

The Nifty Metal index is likely to oscillate between the levels of 6675 and 6580; a pullback should be awaited in Pharma index, says Ravi Nathani

Over 75% pharma stocks eye breakout; most may see up to 15% upside

Barring, Pfizer, Gland Pharma, and Laurus Labs, all other constituents of Nifty Pharm Index trade over the 200-day simple moving average (SMA),

Nifty Pharma nears major hurdle at 14,536; Realty remains range-bound

According to Ravi Nathani, an independent technical analyst, given the overbought conditions on Nifty Pharma traders are advised to book profits and adopt a cash position for near- and short-term.

Nifty Pharma, Realty near key resistance levels; Time to be cautious

According to Ravi Nathani, an independent technical analyst, the Nifty Pharma index needs to clear hurdle at 14,150; whereas, the Realty index may show signs of correction by the month-end.

Nifty Auto in overbought zone; Bullish trend for Pharma index may weaken

The RSI for Nifty Pharma shows a pattern of lower highs and lower lows on the near-term charts; Nifty Auto is in the overbought zone and could see a potential correction

Nifty Metal, Pharma indices exhibit range-bound moves; wait for breakout

Ravi Nathani, independent market analyst shares his trading strategies for Nifty Metal and Nifty Pharma indices; check out

Key levels on Nifty Metal, Pharma, Energy indices to help plan your trade

According to Ravi Nathani, an independent technical analyst, the outlook for Nifty Metal, Energy and Pharma indices is bullish and hence recommends to buy at CMP or on dips.

Nifty Pharma, FMCG indices trading near key resistance zone

According to Ravi Nathani, an independent technical analyst, the Nifty FMCG index is expected to face resistance around 52,250 - 52,375 range; and the Pharma index at 13,425.

Nifty Pharma index may correct in near-term, downside target seen at 12,700

The Nifty Pharma Index is currently trading at a CMP of 12,976.80. The index is expected to undergo a consolidation phase with a negative bias

Nifty Pharma likely to weaken in near-term; adopt sell on rise approach

Nifty Pharma is weak on hourly charts. Traders should be cautious and sell on every rise, while Nifty Energy Index is in a range-bound phase, says Ravi Nathani

Nifty Realty chart indicates likely trend reversal, may slip up to 415

Meanwhile, the Nifty Pharma chart too is flashing caution signal for traders as it too could reverse, says Ravi Nathani, an independent technical analyst.

Nifty Pharma index looks weak on charts; support at 11,700-11,800 levels

Sell the Nifty Pharma index and its constituents and book profits, as the index has been underperforming in recent days

Nifty Pharma likely to remain bearish in near-term, can dip below 12,000

Meanwhile, charts suggest that Nifty Realty and Media indices are experiencing a phase of consolidation says Ravi Nathani, an independent technical analyst.

Charts exhibit bearish trend for Nifty Realty, Pharma indices in near-term

By booking profits and staying away from the market, investors can avoid potential losses and capitalise on future price fluctuations that may occur, said the technical analyst